Gene · 4855
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms and prospects of circular RNAs and their interacting signaling pathways in colorectal cancer. | Front Oncol | 2022 | 35992800 | PubTator, text mining | PubMed |
| NOTCH signaling in COVID-19: a central hub controlling genes, proteins, and cells that mediate SARS-CoV-2 entry, the inflammatory response, and lung regeneration. | Front Cell Infect Microbiol | 2022 | 35992174 | PubTator, text mining | PubMed |
| Covid-19 and adolescent acute kidney injury: Renal recovery with combined enalapril and estrogen therapy. | Clin Chim Acta | 2022 | 35988778 | PubTator, text mining | PubMed |
| The Notch signaling pathway in skeletal muscle health and disease. | Muscle Nerve | 2022 | 35968817 | PubTator, text mining | PubMed |
| NOTCH4 mutation as predictive biomarker for immunotherapy benefits in NRAS wildtype melanoma. | Front Immunol | 2022 | 35967450 | PubTator, text mining | PubMed |
| Molecular mechanism of hyperactive tooth root formation in oculo-facio-cardio-dental syndrome. | Front Physiol | 2022 | 35957990 | PubTator, text mining | PubMed |
| Mesenchymal Stem/Stromal Cells May Decrease Success of Cancer Treatment by Inducing Resistance to Chemotherapy in Cancer Cells. | Cancers (Basel) | 2022 | 35954425 | PubTator, text mining | PubMed |
| A comprehensive multi-omics analysis reveals molecular features associated with cancer via RNA cross-talks in the Notch signaling pathway. | Comput Struct Biotechnol J | 2022 | 35950189 | PubTator, text mining | PubMed |
| Identification of Pathologic Grading-Related Genes Associated with Kidney Renal Clear Cell Carcinoma. | J Immunol Res | 2022 | 35945960 | PubTator, text mining | PubMed |
| The NOTCH4-GATA4-IRG1 axis as a novel target in early-onset colorectal cancer. | Cytokine Growth Factor Rev | 2022 | 35941043 | PubTator, text mining | PubMed |
| Mechanisms of bone remodeling and therapeutic strategies in chronic apical periodontitis. | Front Cell Infect Microbiol | 2022 | 35937695 | PubTator, text mining | PubMed |
| Gene-Based Variant Analysis of Whole-Exome Sequencing in Relation to Eosinophil Count. | Front Immunol | 2022 | 35935937 | PubTator, text mining | PubMed |
| Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma. | Front Mol Neurosci | 2022 | 35935338 | PubTator, text mining | PubMed |
| AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling. | Cell Death Dis | 2022 | 35931701 | PubTator, text mining | PubMed |
| The molecular mechanisms of CTHRC1 in gastric cancer by integrating TCGA, GEO and GSA datasets. | Front Genet | 2022 | 35928443 | PubTator, text mining | PubMed |
| Investigating the molecular mechanisms of Tamoxifen on the EMT pathway among patients with breast cancer. | J Med Life | 2022 | 35928368 | PubTator, text mining | PubMed |
| Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies. | Science | 2022 | 35926050 | PubTator, text mining | PubMed |
| Notch1 and Notch2 Signaling Exclusively but Cooperatively Maintain Fetal Myogenic Progenitors. | Stem Cells | 2022 | 35922037 | PubTator, text mining | PubMed |
| Notch4 affects the proliferation and differentiation of deer antler chondrocytes through the Smad3/lncRNA27785.1 axis. | Cell Signal | 2022 | 35917995 | PubTator, text mining | PubMed |
| Microbiome, Metabolism, and Immunoregulation of Asthma: An American Thoracic Society and National Institute of Allergy and Infectious Diseases Workshop Report. | Am J Respir Cell Mol Biol | 2022 | 35914321 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4855/papers?page=33